SCHEMBL2200890

SCHEMBL2200890

O=C(c1ccc(C(=O)C(F)(F)F)s1)N1CCN(C(=O)C2CCCO2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
NPSR1 Q6W5P4 1/20 0.61
FASN P49327 2/20 0.52
HDAC6 Q9UBN7 3/20 0.50
HDAC1 Q13547 2/20 0.50
CYP2C9 P11712 2/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
HDAC3 O15379 1/20 0.50
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HDAC4 P56524 1/20 0.47
PKM P14618 1/20 0.46
KDM4E B2RXH2 2/20 0.46
TSHR P16473 2/20 0.46
HSD17B10 Q99714 1/20 0.46
POLB P06746 1/20 0.46
HTT P42858 1/20 0.46
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4773133 0.78 L3MBTL3 (0.53) ALDH1A1HDAC6HDAC1CYP2C9HDAC3
SCHEMBL2202532 0.78 HPGD (0.59) ALDH1A1HDAC6HDAC1CYP2C9HDAC3
SCHEMBL17707597 0.76 L3MBTL3 (0.61) ALDH1A1HDAC6HDAC1CYP2C9HDAC3
SCHEMBL2204285 0.75 HDAC6 (0.55) ALDH1A1HDAC6HDAC1CYP2C9HDAC3
SCHEMBL2200435 0.74 HDAC6 (0.59) ALDH1A1HDAC6HDAC1CYP2C9MAPT
SCHEMBL17707579 0.74 HDAC6 (0.56) ALDH1A1HDAC6HDAC1CYP2C9MAPT
Trifluoroacetic Acid SCHEMBL2203749 0.73 L3MBTL1 (0.57) ALDH1A1HDAC6HDAC1CYP2C9LMNA
SCHEMBL16149984 0.72 FASN (0.74) ALDH1A1NPSR1FASNLMNAMAPT
SCHEMBL2203217 0.71 HDAC6 (0.52) ALDH1A1HDAC6HDAC1CYP2C9HDAC3
SCHEMBL2202787 0.71 HDAC6 (0.53) ALDH1A1HDAC6HDAC1CYP2C9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP claimed
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 ALDH1A1 398/4885NPSR1 2561/4885FASN 2598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.